Provention Bio, Inc. Purchase Agreements
7 Contracts & Agreements
- Amendment No. 1 to the Asset Purchase Agreement between Provention Bio, Inc. and MacroGenics, Inc., dated November 30, 2022 (, Exhibit 10.29) (Filed With SEC on March 29, 2023)
- Securities Purchase Agreement, dated October 4, 2022, between Provention Bio, Inc. and Aventis Inc (Filed With SEC on March 24, 2023)
- Form of Purchase Agreement, dated as of July 7, 2022, among Provention Bio, Inc. and each Purchaser party thereto (Filed With SEC on July 8, 2022)
- Asset Purchase Agreement by and between Provention and MacroGenics, Inc. dated May 7, 2018 (Filed With SEC on June 20, 2018)
- Asset Purchase Agreement by and between Provention and MacroGenics, Inc. dated May 7, 2018 (Filed With SEC on June 12, 2018)
- Asset Purchase Agreement by and between Provention and MacroGenics, Inc. dated May 7, 2018 (Filed With SEC on May 16, 2018)
- Form of Securities Purchase Agreement between Provention and investors for an offering completed on April 25, 2017 (Filed With SEC on May 9, 2018)
